Summary: Several investigators haye reported recently that in rats, oral calcium load is associated with a marked ameliöration in gentamicin-induced renal failure. In contrast to these reports, using the same animal model, we could not observe calcium-induced moderation in gentamicin nephrotoxicity äs reflected by either urea or creatinine serum cöncentration or by various renal cortical intracellular enzymatic activities. Similarly, verapamil, a calcium channel blocker, had no effect on the degree of renal failure in these animals. We conclüde that maniptilätion of calcium diet may not be uniformly effective in reducing gentamicin nephrotoxicity. Additional nutritional factors may play a crucial role in achieving the ameliöration of this model of toxic nephropathy.
Introduction
... membrane (4) . Another aspect of calcium metabohsm Nephrotoxicity düe to aininoglycoside treatment is a in uraemia, namely nephrocalcinosis, was recently known clinical complication (1). Lietman et al. (2) investigated by Goligorsky et al. (7) , who found that showed a fall in creatiiiine clearance in 15% of 214 verapamil prevents renal accumulation of calcium in patients treated with aminpglycosides. Factors that ufaemic rats. can reduce nephrotoxicity are of great importance äs they may enäble the use of aniinoglycosides with The aim of the present study was: minimal adverse efifects (3) . In the last decade several tQ jnvesti the effeet of caldum loadi on the investigators have demo^strated that dietary calcmm m^ rf tamicin . induced renal faüure and its supplementation ameliorated gentamicin-mduced on varfous intracdlular renal cortical e renal failure (4) (5) (6) . The protectrve mechamsm was . attributed, at least in part, to a calcium-mediated ' competitive Inhibition of gentamicin binding and up-b) to evaluate the effects of verapamil on this model take along the renal proximal tubular brush border of toxic nephropathy.
Materials and Methods
Male Sprague Dawley rats 6-8 week old, vveighing 150-200 g were used for all studies. Animals vvere divided into six groups (tab. 1). Each group consisted of at least 12 animals. After 10 days all rats vvere sacrificed. Blood for the various examinations was drawn from the aorta. The serum was analysed for creatinine, calcium, phosphorus and magnesium concentration. The kidneys were removed and processed for biochemical analysis. The renal cortex was placed in a 0.02 mol/1 Tris HC1, pH 7.4 buffer (l :10 weight to volume ratio) and homogenized in a PotterElvehjem Glass Teflon homogenizer at 0-4°C. The homogenate was centrifuged in a Sorvall RC 2B centrifuge at 0-4 °C and the various cellular constituents were obtained by using different centrifugal speeds according to a procedure previously described (8) .
Enzyme assays
Aspartate aminotransferase (EC 2.6.1.1), alanine aminotransferase (EC 2.6.1.2), L-iditol dehydrogenase (EC 1.1.1.14) and orthophosphoric-monoester phosphohydrolase (alkaline optimum) (EC 3.1.3.1) of the homogenate and serum were measured spectrophotometrically with a Gilford Autoanalyser at 30 °C by methods previously described (8, 9) . Details of reaction and performance characteristics (within run and run to run) are given (10) . Protein content was determined according to Lowry et al. (11) Urea was determined enzymatically, accordirig to Talke & Schubert (12) and creatinine according to Fabiny & Ertingshausen (13) . The gentamicin bioassay described by Bennet et al. (14) was performed with Muller Hinton Agar plates at pH 8.0, using Bacillus subtilis strain AATC 6633; the analytical r nge was 0.05-3 mg/1 with CV < 2.0% at 1.5 mg/1.
Statistical analysis was performed using Studenfs t test and also by analysis of variance. The results are given in mean ± S. E. M.
Tab. 1. Experimental design.

Results
Mean urea and creatinine concentrations were similar in the control (Group 1), high ealcium diet (Group 3) or verapamil treated (Group 5) rats. The administration of gentamicin resulted in severe renal failure s manifested by the significant increase in serum urea and creatinine concentrations. Neither oral ealcium load nor verapamil had any significant attenuating effect on the degree of renal failure (tab. 2).
Mean activities of sorbitol dehydrogenase, alkaline phosphatase, aspartate aminotransferase and alanine aminotransferase in renal tissue were similar in groups l, 3 and 5. Treatment with gentamicin was associated with a significant reduction in the activities of these enzymes. The addition of ealcium or verapamil did not result in any appreciable attenuation in gentamicin-induced nephrotoxicity (tab. 3).
The relationship between serum urea and creatinine (bpth reliable markers of glomerulaf filtration rate) and cellular enzyme activities was investigated. Both ser m urea and creatinine showed highly significant inverse correlations with the activities of cellular asp artate aminotransferase, alanine aminotransferase, sorbitol dehydrogenase, alkaline phosphatase and lactate dehydrogenase (tab. 4).
No significant decrease was observed in renal tissue gentamicin concentration in rats treated with either oral ealcium load or verapamil (tab. 5).
No. 
Discussion
Nephrotoxicity is a major adverse effect of aminoglycoside antibiotic agents. The renal dysfunction due to gentamicin treatment in humans has been related to several risk factors (2, 3, 15, 16 ). The precise intracellular targets that are affected by these agents, leading to renal damage are uncertain. Plasma membrane and lysosomal phospholipases, basolateral membrane Na+-K + -ATPase and mitochondrial membranes have been proposed (17) (18) (19) (20) . Recently gentamicin-induced decreases in mitochondrial cytochrome enzyme concentrations were observed, suggesting the pqssibility that the renal tubular cell protein synthetic mechanisms are disturbed by this agent (21) . The wide use of these antibiotic agents and their major contribution in the treatment of various infectious prpcesses have initiated a seareh for treatment modalities which may eliminate or amelioräte their nephTab. 5 . Gentamicin values (mg/g protein) in renal tissue. rotoxic effect. It has been shown that hydroxyl radical scavengers such äs dimethylthiourea, dimethyl sulphoxide and sodium benzoate or deferoxamine (a potent iron chelator) may moderate the gentamicininduced renal failure in rats (22) .
Several investigators have dernonstrated that the administration of calcium to rats also ameliorated gentamicin nephrotoxicity (4 -6). The mechanism by which this phenomenon is achieved is unclear. It has been suggested that calcium may act äs a competitive inhibitor, modifying gentamicin interaction with critical subcellular membrane sites of the renal proximal tubule (6) . In the present study the administration of gentamicin to rats was associated with severe nephrotoxicity äs evidenced by impairment of both kidney function (increased urea and creatinine) and metabolism (decrease in various cellular enzymatic activities). In agreement with others (4-6) a high calcium diet was not associated with a lower gentamicin concentration in the renal cortex. However, in contrast to previous reports (2-4), we did not observe any significant amelioration in the degree of nephrotoxicity. This difference in observations can not.be explained on a basis of different protocols. Calcium concentration in the diet was similar to that used by others (4) (5) (6) . The time elapsing between the initiation of calcium loading and the administration of gentamicin, and the dosage of gentamicin were identical to those of a previously used study protocol (6) . It has been shown that calcium loading in the presence of high sodium intake-induced volume expansion, may not be protective against renal cell injury caused by gentamicin (6) . Dietary restriction of protein intake may also moderate to some degree aminoglycoside nephrotoxicity (23) . We did not monitor the sodium or protein intake. It may well be that the differing results in our study at least in part, reflect nutritional factors. Nephrocalcinosis is a common complication of the uraemic state and may play a decisive role in its Progression. Gentamicin nephrotoxicity is associated with a significant increase in cellular calcium concentration (6, 24) . The main site of its accumulation seems to be within the mitochondria (24) . Recently it has been shown that verapamil, a potent calcium-channel blocker may prevent nephrocalcinosis (7) . In our study we could not demonstrate any amelioration of gentamicin-induced nephrotoxicity by either kidney function indices or enzymatic-metabolic ones. The administration of verapamil also had no effect on renal tissue gentamicin concentration. Of special interest are the significant correlations between renal function indices such äs urea and creatinine, and various enzyme activities. These inverse relationships, which to the best of our knowledge have never been reported previously, demonstrate the direct depencU ence of glomerular filtration on enzymatic metabolic activities. We conclude that oral calcium supplementation dpes not ameliorate gentamicin-induced nephrotoxicity, unless other metabolic or nutritional factors afe strictly controlled. Calcium channel blockers do not prevent or moderate the gentamicin-induced renal failure. Changes in metabolism, äs reflected by a marked reduction in intracellular enzyme activities, correläte significantly with the degree of gentamicininduced impairment in glomerular filtration.
